LEPU ScienTech Medical Technology (Shanghai) Temettü
Temettü kriter kontrolleri 1/6
LEPU ScienTech Medical Technology (Shanghai) is a dividend paying company with a current yield of 3.76%.
Anahtar bilgiler
3.8%
Temettü verimi
-5.7%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -2.0% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | HK$0.617 |
| Ödeme oranı | 91% |
Son temettü güncellemeleri
Recent updates
Returns On Capital Signal Tricky Times Ahead For LEPU ScienTech Medical Technology (Shanghai) (HKG:2291)
Oct 03
There's Reason For Concern Over LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Massive 36% Price Jump
Jul 03There Are Reasons To Feel Uneasy About LEPU ScienTech Medical Technology (Shanghai)'s (HKG:2291) Returns On Capital
Jun 09LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital
Mar 03The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence
Nov 09LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit
Aug 14Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Too early to tell whether 2291's dividend payments have been stable as they only just started paying a dividend.
Büyüyen Temettü: Too early to tell if 2291's dividend payments are increasing as they only just started paying a dividend.
Piyasaya Karşı Temettü Getirisi
| LEPU ScienTech Medical Technology (Shanghai) Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (2291) | 3.8% |
| Pazarın Alt %25'i (HK) | 3.2% |
| Pazarın En İyi %25'i (HK) | 7.9% |
| Sektör Ortalaması (Medical Equipment) | 3.3% |
| Analist tahmini (2291) (3 yıla kadar) | n/a |
Önemli Temettü: 2291's dividend (3.76%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.25%).
Yüksek Temettü: 2291's dividend (3.76%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.92%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its high payout ratio (91.4%), 2291's dividend payments are not well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its high cash payout ratio (167.3%), 2291's dividend payments are not well covered by cash flows.